Actavis will lay off more than 30% of the sales staff from its branded-drugs division as part of its acquisition of Warner Chilcott, the drug maker said.
Actavis has appointed the board of directors for the division it recently created as part of its acquisition of Ireland-based Warner Chilcott, the drug maker said.
Actavis will acquire Warner Chilcott for $8.5 billion, the drug maker said.
Actavis is continuing to pursue a plan to buy Irish drug maker Warner Chilcott, as the U.S.-based company announced Tuesday its total number of shares and share-purchase options in order to comply with Ireland's merger-and-acquisition rules.
Actavis is looking into the possibility of buying Warner Chilcott, the generic drug maker said.
The Food and Drug Administration has approved a new strength of an antibiotic made by Warner Chilcott, the drug maker said.
Quarterly revenue for Warner Chilcott during the third quarter primarily was driven by the company's...